OSlihc: An Online Prognostic Biomarker Analysis Tool for Hepatocellular Carcinoma

Liver hepatocellular carcinoma (LIHC) is one of the most common malignant tumors in the world with an increasing number of fatalities. Identification of novel prognosis biomarker for LIHC may improve treatment and therefore patient outcomes. The availability of public gene expression profiling data...

Descripción completa

Detalles Bibliográficos
Autores principales: An, Yang, Wang, Qiang, Zhang, Guosen, Sun, Fengjie, Zhang, Lu, Li, Haojie, Li, Yingkun, Peng, Yanyu, Zhu, Wan, Ji, Shaoping, Guo, Xiangqian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298068/
https://www.ncbi.nlm.nih.gov/pubmed/32587519
http://dx.doi.org/10.3389/fphar.2020.00875

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7298068/
https://www.ncbi.nlm.nih.gov/pubmed/32587519
http://dx.doi.org/10.3389/fphar.2020.00875

Ejemplares similares